Adexilis is proud to announce that effective January 1, 2022 Adexilis Romania s.r.o. became promotional partner of Bausch Health in Romania. Dan Captaru, Managing Partner of Adexilis Romania: “We are very excited supporting Bausch Health by providing a valuable product like Arefam to patients in need”.Read More
We are proud to announce that ADEXILIS will represent VSL#3 in our markets. Between May 2021 and August 2021 we will take over the representation from Ferring. With VSL#3 we will be strengthen our Gastroenterology portfolio and are able to provide VSL#3® as a multi-strain bacterial mix product distributed in all markets under the same...Read More
We are excited to announce that ADEXILIS Turkey launched just in time for 2020 its new digital healthcare platform sagligadestek.com. Patient centricity is a key element of our strategy. Providing our customers and patients in need clearly differentiated and superior products is our aim, coupled with a clear focus to provide true value information to...Read More
ADEXILIS is happy to announce that we obtained reimbursement for another life saving therapy in Czech Republic. Together with our partner we demonstrated our ability to authorities the true value of our therapy. Jiri Kubacek, General Manager Adexilis Czech Republic and Slovakia states: “We are excited to bring this superior ECP therapy to patients that...Read More
Peptonic Medical today announced that it has entered an agreement with ADEXILIS Service Kft. concerning the marketing, sales and distribution of VagiVital® in Hungary, Slovakia and Croatia. Under the agreement, Adexilis is granted the exclusive commercial rights to VagiVital® in the above mentioned countries. In return, Adexilis has committed to annual minimum purchase volumes of...Read More
DxNow is combining novel, portable bio-imaging systems with microfluidic-based consumables for life science applications leveraging exclusively licensed technologies developed in the Demirci Bio-Acoustic MEMS in Medicine Labs (BAMM Labs) at Harvard Medical School/Brigham & Women’s Hospital and Stanford Medicine. The Future of fertility has arrived Our initial products address significant market needs in fertility clinics...Read More
Mallinckrodt Pharmaceuticals, a global leader in Extracorporeal Photopheresis (ECP), is committed to providing the highest quality technologies and services to allow you to deliver optimized ECP Immunomodulation to your patients. The Therakos™ ECP Immunomodulation therapeutic platforms, including THERAKOS™ CELLEX™ Photopheresis System, our latest advancement technology, are the only approved, fully-integrated ECP immunomodulation platforms. Therakos’ Integrated...Read More
OCON is pleased to announce that it has partnered with Adexilis for distribution of its products in Hungary and Slovakia. The IUB is a true innovation in Women`s Health and contraception combining the superior efficacy of IUD with an improved side effect profile vs. Hormonal Contraception and “old-fashioned IUD” through its innovative shape and approach....Read More
We are using cookies to give you the best experience. You can find out more about which cookies we are using or switch them off in privacy settings.
